secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001104659-25-108844
Event type: other_material
Sentiment:  negative
Materiality: 0.78
Item codes: 1.01, 2.03, 3.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

KALA Bio enters $375k convertible loan; Oxford pauses foreclosure, company faces cash crunch
--------------------------------------------------------------------------------

- Convertible loan of up to $375k from individual investor; first $187.5k due Nov 10, remainder by Nov 12, 2025.
- Loan bears 15% simple interest; lender can convert into common stock at defined prices.
- Proceeds limited to negotiating further investment with lender and preparing Q3 2025 Form 10-Q.
- Oxford paused asset foreclosure on Nov 3. If no additional financing, foreclosure expected to resume.
- Company cannot seek alternative offers from others until Nov 17, 2025; warns of going-concern risk.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000110465925108844/0001104659-25-108844-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000110465925108844/kala-20251109x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-108844

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer